Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma

Neurosurgery

Volumn 63, Issue 4, 2008, Pages 720-726

  Chamberlain, Marc C ^a,c   Glantz, Michael J ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c MS G 4940 ^*  (United States)

Author keywords

Hemangiopericytoma; Intracranial; Recurrent; Sequential chemotherapy

Indexed keywords

ALPHA INTERFERON; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOLASETRON MESILATE; DOXORUBICIN; ETOPOSIDE; GRANISETRON; IFOSFAMIDE; MESNA; ONDANSETRON; VINCRISTINE;

ADULT; ALOPECIA; ANEMIA; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE COURSE; DISEASE FREE SURVIVAL; DISSEMINATED CANCER; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEMANGIOPERICYTOMA; HUMAN; INTRACRANIAL HEMANGIOPERICYTOMA; INTRACRANIAL TUMOR; MALE; MULTIPLE CYCLE TREATMENT; NEUROLOGIC EXAMINATION; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALVAGE THERAPY; STEREOTACTIC RADIOSURGERY; STEREOTACTIC TREATMENT; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT FAILURE; TUMOR RECURRENCE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOXORUBICIN; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HEMANGIOPERICYTOMA; HUMANS; IFOSFAMIDE; INTERFERON-ALPHA; KAPLAN-MEIERS ESTIMATE; LIPOSOMES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RARE DISEASES; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 56749153813     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000325494.69836.51     Document Type: Article

References (19)

1. Bramwell VH, Anderson D, Charette ML: Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma. Cochrane Database Syst Rev 3:CD003293, 2003.
2. Coffey RJ, Cascino TL, Shaw EG: Radiosurgical treatment of recurrent hemangiopericytomas of the meninges: Preliminary results. J Neurosurg 78:903-908, 1993.
3. D'Adamo DR, Anderson SE, Albritton K, Yamada J, Riedel E, Scheu K, Schwartz GK, Chen H, Maki RG: Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas. J Clin Oncol 23:7135-7142, 2005.
4. Dufour H, Métellus P, Fuentes S, Murracciole X, Régis J, Figarella-Branger D, Grisoli F: Meningeal hemangiopericytoma: A retrospective study of 21 patients with special review of postoperative external radiotherapy. Neurosurgery 48:756-763, 2001.
5. Espat NJ, Lewis JJ, Leung D, Woodruff JM, Antonescu CR, Shia J, Brennan MF: Conventional hemangiopericytoma: Modern analysis of outcome. Cancer 95:1746-1751, 2002.
6. Galanis E, Buckner JC, Scheithauer BW, Kimmel DW, Schomberg PJ, Piepgras DG: Management of recurrent meningeal hemangiopericytoma. Cancer 82:1915-1920, 1998.
7. Kaba SE, DeMonte F, Bruner JM, Kyritsis AP, Jaeckle KA, Levin V, Yung WK: The treatment of recurrent unresectable and malignant meningiomas with interferon α-2B. Neurosurgery 40:271-275, 1997.
8. Kim JH, Jung HW, Kim YS, Kim CJ, Hwang SK, Paek SH, Kim DG, Kwun BD: Meningeal hemangiopericytomas: Long-term outcome and biological behavior. Surg Neurol 59:47-54, 2003.
9. Kirn DH, Kramer A: Long-term freedom from disease progression with interferon alfa therapy in two patients with malignant hemangiopericytoma. J Natl Cancer Inst 88:764-765, 1996.
10. Lackner H, Urban C, Dornbusch HJ, Schwinger W, Kerbl R, Sovinz P: Interferon alfa-2a in recurrent metastatic hemangiopericytoma. Med Pediatr Oncol 40:192-194, 2003.
11. Lorigan P, Verweij J, Papai Z, Rodenhuis S, Le Cesne A, Leahy MG, Radford JA, Van Glabbeke MM, Kirkpatrick A, Hogendoorn PC, Blay JY: Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group study. J Clin Oncol 25:3144-3150, 2007.
12. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277-1280, 1990.
13. Mena H, Ribas JL, Pezeshkpour GH, Cowan DN, Parisi JE: Hemangiopericytoma of the central nervous system: A review of 94 cases. Hum Pathol 22:84-91, 1991.
14. Payne BR, Prasad D, Steiner M, Steiner L: Gamma surgery for hemangiopericytomas. Acta Neurochir (Wien) 142:527-537, 2000.
15. Rajaram V, Brat DJ, Perry A: Anaplastic meningioma versus meningeal hemangiopericytoma: Immunohistochemical and genetic markers. Hum Pathol 35:1413-1418, 2004.
16. Sheehan J, Kondziolka D, Flickinger J, Lunsford LD: Radiosurgery for treatment of recurrent intracranial hemangiopericytomas. Neurosurgery 51:905-911, 2002.
17. Stout AP, Murray MR: Hemangiopericytoma: A vascular tumor featuring Zimmermann's pericytes. Ann Surg 116:26-33, 1942.
18. Soyuer S, Chang EL, Selek U, McCutcheon IE, Maor MH: Intracranial meningeal hemangiopericytoma: The role of radiotherapy: Report of 29 cases and review of the literature. Cancer 100:1491-1497, 2004.
19. Wöber-Bringöl C, Wöber C, Marosi C, Prayer D: Interferon-alfa-2b for meningioma. Lancet 345:331, 1995.